ASH News Daily 2012 - Saturday, December 8, 2012 - (Page B-39)

VISIT BOOTH #2805 AT THE 2012 ASH ANNUAL CONFERENCE Image: Colored scanning electron micrograph (SEM) of a lymphoma cancer cell. One focus: a shared commitment to improve the lives of cancer patients everywhere. Millennium: The Takeda Oncology Company is developing an extensive pipeline — among the top in oncology worldwide — with more than 17 compounds in development for a broad range of solid and hematological cancers. Our pipeline — rich in novel compounds — includes multiple candidates that target seven disease pathways: protein homeostasis, anti-angiogenesis, growth-signaling inhibition, cell-cycle inhibition, apoptosis, immunomodulators and hormone regulation. To make a dramatic impact on cancer therapeutics, we are dedicated to a strong partnership with the oncology community. Stop by the Millennium booth to learn more about our commitment and take part in our 1000 Cranes of Hope Initiative. WHAT IS YOUR WISH? Visit the 1000 Cranes of Hope exhibit to help in the advancement of research and patient support. As each person’s wishes and dreams join ours, Millennium will provide a charitable grant to the ASH Clinical/Translational Scholar Awards in support of quality research that will have an impact on current and future patients. JOIN US AT BOOTH #2805 TO ENJOY CUPCAKES, FRUIT INFUSED WATER, AND GOURMET COFFEE DURING EXHIBIT HOURS. To learn more, visit us at millennium.com. ©2012 Millennium Pharmaceuticals, Inc. All rights reserved. ASH Daily_10x14.indd 1 10/22/12 11:37 AM 

Table of Contents for the Digital Edition of ASH News Daily 2012 - Saturday, December 8, 2012

ASH News Daily 2012 - Saturday, December 8, 2012

https://www.nxtbookmedia.com